Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?
Aminopeptidase N (APN/CD13) is a multifunctional glycoprotein that acts as a peptidase, receptor, and signalling molecule in a tissue-dependent manner. The activities of APN have been implicated in the progression of many cancers, pointing toward significant therapeutic potential for cancer treatmen...
Saved in:
| Published in | Biochimica et biophysica acta. Reviews on cancer Vol. 1876; no. 2; p. 188641 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier B.V
01.12.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Aminopeptidase N (APN/CD13) is a multifunctional glycoprotein that acts as a peptidase, receptor, and signalling molecule in a tissue-dependent manner. The activities of APN have been implicated in the progression of many cancers, pointing toward significant therapeutic potential for cancer treatment. However, despite the tumour-specific functions of this protein that have been uncovered, the ubiquitous nature of its expression in normal tissues as generally reported remains a limitation to the potential utility of APN as a target for cancer therapeutics and drug discovery. With this in mind, we have extensively explored the literature, and present a comprehensive review that for the first-time provides evidence to support the suggestion that tumour-expressed APN may in fact be unique in structure, function, substrate specificity and activity, contrary to its nature in normal tissues. The review also focuses on the biology of APN, and its “moonlighting” functional roles in both normal physiology and cancer development. Several APN-targeting approaches that have been explored over recent decades as therapeutic strategies in cancer treatment, including APN-targeting agents reported both in preclinical and clinical studies, are also extensively discussed. This review concludes by posing critical questions about APN that remain unanswered and unexplored, hence providing opportunities for further research. |
|---|---|
| AbstractList | Aminopeptidase N (APN/CD13) is a multifunctional glycoprotein that acts as a peptidase, receptor, and signalling molecule in a tissue-dependent manner. The activities of APN have been implicated in the progression of many cancers, pointing toward significant therapeutic potential for cancer treatment. However, despite the tumour-specific functions of this protein that have been uncovered, the ubiquitous nature of its expression in normal tissues as generally reported remains a limitation to the potential utility of APN as a target for cancer therapeutics and drug discovery. With this in mind, we have extensively explored the literature, and present a comprehensive review that for the first-time provides evidence to support the suggestion that tumour-expressed APN may in fact be unique in structure, function, substrate specificity and activity, contrary to its nature in normal tissues. The review also focuses on the biology of APN, and its "moonlighting" functional roles in both normal physiology and cancer development. Several APN-targeting approaches that have been explored over recent decades as therapeutic strategies in cancer treatment, including APN-targeting agents reported both in preclinical and clinical studies, are also extensively discussed. This review concludes by posing critical questions about APN that remain unanswered and unexplored, hence providing opportunities for further research.Aminopeptidase N (APN/CD13) is a multifunctional glycoprotein that acts as a peptidase, receptor, and signalling molecule in a tissue-dependent manner. The activities of APN have been implicated in the progression of many cancers, pointing toward significant therapeutic potential for cancer treatment. However, despite the tumour-specific functions of this protein that have been uncovered, the ubiquitous nature of its expression in normal tissues as generally reported remains a limitation to the potential utility of APN as a target for cancer therapeutics and drug discovery. With this in mind, we have extensively explored the literature, and present a comprehensive review that for the first-time provides evidence to support the suggestion that tumour-expressed APN may in fact be unique in structure, function, substrate specificity and activity, contrary to its nature in normal tissues. The review also focuses on the biology of APN, and its "moonlighting" functional roles in both normal physiology and cancer development. Several APN-targeting approaches that have been explored over recent decades as therapeutic strategies in cancer treatment, including APN-targeting agents reported both in preclinical and clinical studies, are also extensively discussed. This review concludes by posing critical questions about APN that remain unanswered and unexplored, hence providing opportunities for further research. Aminopeptidase N (APN/CD13) is a multifunctional glycoprotein that acts as a peptidase, receptor, and signalling molecule in a tissue-dependent manner. The activities of APN have been implicated in the progression of many cancers, pointing toward significant therapeutic potential for cancer treatment. However, despite the tumour-specific functions of this protein that have been uncovered, the ubiquitous nature of its expression in normal tissues as generally reported remains a limitation to the potential utility of APN as a target for cancer therapeutics and drug discovery. With this in mind, we have extensively explored the literature, and present a comprehensive review that for the first-time provides evidence to support the suggestion that tumour-expressed APN may in fact be unique in structure, function, substrate specificity and activity, contrary to its nature in normal tissues. The review also focuses on the biology of APN, and its “moonlighting” functional roles in both normal physiology and cancer development. Several APN-targeting approaches that have been explored over recent decades as therapeutic strategies in cancer treatment, including APN-targeting agents reported both in preclinical and clinical studies, are also extensively discussed. This review concludes by posing critical questions about APN that remain unanswered and unexplored, hence providing opportunities for further research. |
| ArticleNumber | 188641 |
| Author | Falconer, Robert A. Barnieh, Francis M. Loadman, Paul M. |
| Author_xml | – sequence: 1 givenname: Francis M. surname: Barnieh fullname: Barnieh, Francis M. email: f.mprahbarnieh1@bradford.ac.uk – sequence: 2 givenname: Paul M. surname: Loadman fullname: Loadman, Paul M. – sequence: 3 givenname: Robert A. surname: Falconer fullname: Falconer, Robert A. email: r.a.falconer1@bradford.ac.uk |
| BookMark | eNqFkE1LxDAQhoMouH78Ai896qFrpmm76UFE1k8Q9aDgLcxOp5Clm9YkFf33dl1PHvQ0MMwz78yzJ7Zd51iII5BTkFCeLqeLBaGbZjKDKWhd5rAlJqBnVZoVJWyLiVQyT3OoXnfFXghLKaFQqpyIl7uQxGHVDT7lj95zCFwnuLKu67mPtsbAyUNyfPH0cDq_BHWShOgHioPHtv1M0NVJMziKtnPfjcHZt4HPD8ROg23gw5-6L16ur57nt-n9483d_OI-pTE8prOaSbNGpUkCEtY5gsqwbqp8IYFQVYC6oILyBrHJiowYNGYaZk2zkEWu9sXxZm_vuzE3RLOygbht0XE3BJMVo4rx0aocR6vNKPkuBM-NIRtxfXj0aFsD0qxVmqX5VmnWKs1G5ciqX2zv7Qr95z_U2Ybi0cC7ZW8CWXbEtfVM0dSd_ZP_As5DkRU |
| CitedBy_id | crossref_primary_10_6023_cjoc202312029 crossref_primary_10_3390_nano13152229 crossref_primary_10_1002_advs_202403831 crossref_primary_10_1097_RLU_0000000000005647 crossref_primary_10_1039_D4RA00127C crossref_primary_10_1002_chem_202300655 crossref_primary_10_1016_j_isci_2023_108219 crossref_primary_10_3390_ijms25189779 crossref_primary_10_3390_md21050279 crossref_primary_10_1016_j_trac_2023_117335 crossref_primary_10_3390_cancers15184459 crossref_primary_10_1002_ange_202217408 crossref_primary_10_1515_biol_2022_0637 crossref_primary_10_3389_fcell_2024_1359105 crossref_primary_10_3390_pharmaceutics15020491 crossref_primary_10_1515_pac_2023_0214 crossref_primary_10_3390_bios14100501 crossref_primary_10_1002_adom_202102709 crossref_primary_10_1002_anie_202217408 crossref_primary_10_1039_D4TB00066H crossref_primary_10_1016_j_cclet_2023_108948 crossref_primary_10_1002_adma_202305243 crossref_primary_10_1021_acs_jafc_4c07713 crossref_primary_10_3390_biomedicines11030724 crossref_primary_10_1007_s00259_023_06412_z crossref_primary_10_1007_s00259_025_07140_2 crossref_primary_10_1016_j_ijbiomac_2022_12_280 crossref_primary_10_1016_j_molstruc_2024_139394 crossref_primary_10_1039_D3BM00007A crossref_primary_10_1186_s12885_024_12113_z crossref_primary_10_1515_psr_2022_0288 |
| Cites_doi | 10.2174/092986707780059571 10.1136/jcp.47.1.43 10.1042/bj3390497 10.1186/s13045-020-00865-7 10.1016/S0167-5699(98)01398-X 10.1007/BF00163576 10.1016/j.cell.2011.02.013 10.1080/10623320390272334 10.1039/C5SC03600C 10.1128/JVI.75.20.9741-9752.2001 10.1172/JCI114015 10.1186/1471-2407-7-140 10.1016/j.jaut.2006.02.003 10.1038/nsmb.3048 10.1016/S0304-3835(02)00086-1 10.1053/gast.2002.31095 10.1097/JIM.0000000000000199 10.1038/sj.leu.2401388 10.1007/s00296-003-0292-5 10.1007/s00726-013-1648-0 10.18632/oncotarget.18420 10.1073/pnas.1120790109 10.1021/bc070031k 10.1016/j.bcp.2009.12.022 10.1159/000474984 10.2174/1389200013338748 10.1038/357420a0 10.1182/blood.V95.2.453 10.1158/1535-7163.MCT-08-0735 10.1182/blood.V79.12.3344.bloodjournal79123344 10.7164/antibiotics.43.143 10.1073/pnas.1210123109 10.1016/0006-2952(90)90348-O 10.1002/pros.20775 10.1111/j.1432-1033.1991.tb15828.x 10.1128/jvi.67.11.6576-6585.1993 10.1093/jnci/94.13.1020 10.1016/j.bmc.2012.12.038 10.1158/1078-0432.CCR-05-1005 10.1002/prca.201300118 10.1200/JCO.2009.27.3649 10.1016/j.molmed.2008.06.003 10.1002/1097-0142(19890915)64:6<1274::AID-CNCR2820640618>3.0.CO;2-2 10.1126/science.291.5512.2364 10.1016/S0021-9258(17)38851-8 10.1093/ajcp/105.6.761 10.4103/0973-1482.138007 10.1093/cvr/cvt155 10.1183/13993003.01610-2017 10.1038/sj.bjc.6605162 10.1002/ijc.2910540122 10.1158/1078-0432.CCR-06-0338 10.1182/blood.V97.3.652 10.1136/jcp.2005.026328 10.1007/s12185-013-1397-6 10.1016/j.canlet.2004.06.050 10.1038/s41598-017-01542-5 10.1006/bbrc.1995.1390 10.1007/s12185-011-0900-1 10.1038/ki.2014.387 10.1074/jbc.M109.060418 10.1074/jbc.M112.398842 10.1189/jlb.1204714 10.1111/j.1525-1438.2006.00657.x 10.1016/0005-2736(80)90190-X 10.1056/NEJM195809042591003 10.1038/sj.bjc.6603157 10.3390/cancers13071527 10.1016/0014-5793(94)01079-X 10.1016/0268-960X(92)90020-Q 10.1021/bi00330a011 10.1016/S2352-3026(20)30044-2 10.1038/bjc.2012.549 10.1007/s10637-007-9092-1 10.1248/bpb.19.6 10.1021/acs.jmedchem.7b00782 10.1369/jhc.2010.956644 10.1002/cam4.3300 10.1074/jbc.M603191200 10.1182/blood.V75.2.462.462 10.1016/j.jhep.2009.02.033 10.1007/s11748-009-0445-x 10.1007/s12032-011-9984-y 10.2174/157340611794072706 10.1016/S1535-6108(04)00025-X 10.3892/or.2016.4611 10.1093/clinchem/45.10.1797 10.1056/NEJM196012222632503 10.1096/fasebj.7.2.8440407 10.1016/S0021-9258(18)99056-3 10.1007/s10741-007-9061-y 10.18632/oncotarget.12835 10.3892/or.2014.3693 10.1002/med.20044 10.1016/j.bbagen.2018.05.013 10.1158/0008-5472.CAN-07-6627 10.1073/pnas.0611653104 10.1159/000054439 10.1038/bjc.2012.233 10.1016/S0016-5085(60)80084-4 10.1038/nrc3982 10.1016/0020-711X(91)90116-5 10.1021/bi971705p 10.1111/j.1349-7006.2010.01826.x 10.1152/physrev.1982.62.1.91 |
| ContentType | Journal Article |
| Copyright | 2021 Elsevier B.V. Copyright © 2021 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2021 Elsevier B.V. – notice: Copyright © 2021 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION 7X8 |
| DOI | 10.1016/j.bbcan.2021.188641 |
| DatabaseName | CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology |
| EISSN | 1879-2561 |
| ExternalDocumentID | 10_1016_j_bbcan_2021_188641 S0304419X21001396 |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABBQC ABEFU ABFNM ABGSF ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HLW HMK HMO HVGLF HZ~ IHE J1W KOM LCYCR LX3 M29 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 PC. Q38 R2- ROL RPZ SAE SBG SDF SDG SDP SES SEW SPCBC SSH SSU SSZ T5K UQL WUQ XJT XPP ZE2 ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION 7X8 |
| ID | FETCH-LOGICAL-c336t-7dec8e8a38c01acad4a132adf94b01ca391a85c5c4faaf252ce18a2817ffb0543 |
| IEDL.DBID | .~1 |
| ISSN | 0304-419X 1879-2561 |
| IngestDate | Thu Jul 10 19:00:40 EDT 2025 Thu Apr 24 23:04:19 EDT 2025 Tue Jul 01 00:21:54 EDT 2025 Fri Feb 23 02:46:06 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Aminopeptidase CD13 Protease Aminopeptidase N APN Cancer |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c336t-7dec8e8a38c01acad4a132adf94b01ca391a85c5c4faaf252ce18a2817ffb0543 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PQID | 2586453396 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2586453396 crossref_citationtrail_10_1016_j_bbcan_2021_188641 crossref_primary_10_1016_j_bbcan_2021_188641 elsevier_sciencedirect_doi_10_1016_j_bbcan_2021_188641 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | December 2021 2021-12-00 20211201 |
| PublicationDateYYYYMMDD | 2021-12-01 |
| PublicationDate_xml | – month: 12 year: 2021 text: December 2021 |
| PublicationDecade | 2020 |
| PublicationTitle | Biochimica et biophysica acta. Reviews on cancer |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Helenius, Aebi (bb0630) 2001; 291 Söderberg, Giugni, Zaia, Larsson, Wahlberg, Möller (bb0315) 1993; 67 Guzman-Rojas, Rangel, Salameh, Edwards, Dondossola, Kim, Saghatelian, Giordano, Kolonin, Staquicini, Koivunen, Sidman, Arap, Pasqualini (bb0400) 2012; 109 Amin, Adhikari, Jha (bb0340) 2018; 61 Sobol-Milejska, Mizia-Malarz, Wos (bb0475) 2013; 98 Dixon, Kaklamanis, Turley, Hickson, Leek, Harris, Gatter (bb0205) 1994; 47 Turner (bb0240) 2013 Kakinuma, Ohta, Kamiya, Yamazaki, Oikawa, Okada, Nakauchi (bb0215) 2009; 51 Shapiro, Ashmun, Roberts, Look (bb0230) 1991; 266 Carl-McGrath, Lendeckel, Ebert, Wolter, Roessner, Rocken (bb0390) 2004; 25 Bauvois, Dauzonne (bb0415) 2006; 26 Saiki, Fujii, Yoneda, Abe, Nakajima, Tsuruo, Azuma (bb0405) 1993; 54 Wickstrom, Viktorsson, Lundholm, Aesoy, Nygren, Sooman, Fryknas, Vogel, Lewensohn, Larsson, Gullbo (bb0515) 2010; 79 Oconnell, Gerkis, Dapice (bb0155) 1991; 266 Liu, Xie, Wang, Liu, Liu, Sun, Niu (bb0375) 2015; 33 Schmidt, Brand, Stucke-Ring, Schliemann, Kessler, Harrach, Mohr, Görlich, Marra, Hillejan, Müller-Tidow, Lenz, Wardelmann, Wiewrodt, Berdel, Schwöppe, Hartmann (bb0445) 2017; 12 Nanus (bb0020) 2003; 9 Ito, Miyahara, Takahashi, Nagai, Takenaka, Wada, Tanaka (bb0435) 2009; 57 Otsuki, Nakashima, Hamada, Takayama, Akita, Masuda, Horimasu, Miyamoto, Iwamoto, Fujitaka, Miyata, Miyake, Kohno, Okada, Hattori (bb0485) 2018; 51 (bb0145) 1980; 599 (bb0325) 2007 Gregorc, Gaafar, Favaretto, Grossi, Jassem, Polychronis, Bidoli, Tiseo, Shah, Taylor, Novello, Muzio, Bearz, Greillier, Fontana, Salini, Lambiase, O'Brien (bb0595) 2018; 19 Nakase, Kita, Shiku, Tanaka, Nasu, Dohy, Kyo, Tsutani, Kamada (bb0290) 1996; 105 Pang, Zhang, Xia, Wang, Wang, Meng (bb0310) 2016; 7 Martinez, Prieto, Ramirez, Cueva, Alba, Ramirez (bb0010) 1999; 45 Ranogajec, Jakic-Razumovic, Puzovic, Gabrilovac (bb0450) 2012; 29 Lorusso, Scambia, Amadio, di Legge, Pietragalla, De Vincenzo, Masciullo, Di Stefano, Mangili, Citterio, Mantori, Lambiase, Bordignon (bb0600) 2012; 107 Hooper (bb0185) 1994; 354 Kawamura, Shimada, Kitaichi, Komoto, Hashimoto, Kaganoi, Miyake, Yamasaki, Kondo, Imamura (bb0550) 2007; 54 van Hensbergen, Broxterman, Hanemaaijer, Jorna, van Lent, Verheul, Pinedo, Hoekman (bb0035) 2002; 8 Röcken, Licht, Roessner, Carl-McGrath (bb0470) 2005; 58 Gros, Giros, Schwartz (bb0195) 1985; 24 Schreiber, Smith (bb0080) 2018; I Lendeckel, Kahne, Riemann, Neubert, Arndt, Reinhold (bb0265) 2000; 477 Curnis, Arrigoni, Sacchi, Fischetti, Arap, Pasqualini, Corti (bb0225) 2002; 62 Scornik, Botbol (bb0535) 2001; 2 Helene, Beaumont, Roques (bb0190) 1991; 196 Hanahan, Weinberg (bb0350) 2011; 144 Schmitt, Voegelin, Marin, Schmitt, Schegg, Henon, Guenot, Tarnus (bb0510) 2013; 21 Wong, Zhou, Rini (bb0165) 2012; 287 Kehlen, Lendeckel, Dralle, Langner, Hoang-Vu (bb0505) 2003; 63 Yoneda, Saiki, Fujii, Abe, Kojima, Azuma (bb0070) 1992; 10 (bb0180) 2012; 109 Wickstrom, Haglund, Lindman, Nygren, Larsson, Gullbo (bb0560) 2008; 26 Marchio, Lahdenranta, Schlingemann, Valdembri, Wesseling, Arap, Hajitou, Ozawa, Trepel, Giordano, Nanus, Dijkman, Oosterwijk, Sidman, Cooper, Bussolino, Pasqualini, Arap (bb0090) 2004; 5 Pfleiderer, Celliers (bb0140) 1963; 339 Pineda, Goldbarg, Banks, Rutenburg (bb0055) 1960; 38 Reaux, de Mota, Zini, Cadel, Fournie-Zaluski, Roques, Corvol, Llorens-Cortes (bb0255) 1999; 69 Rangel, Sun, Guzman-Rojas, Ozawa, Sun, Giordano, Van Pelt, Tinkey, Behringer, Sidman, Arap, Pasqualini (bb0410) 2007; 104 Matteo, Arrigoni, Alberici, Corti, Gallo-Stampino, Traversari, Doglioni, Rizzardi (bb0605) 2011; 59 Pasqualini, Koivunen, Kain, Lahdenranta, Sakamoto, Stryhn, Ashmun, Shapiro, Arap, Ruoslahti (bb0220) 2000; 60 Danziger (bb0260) 2008; 13 Terauchi, Kajiyama, Shibata, Ino, Nawa, Mizutani, Kikkawa (bb0370) 2007; 7 Luciani, Marie-Claire, Ruffet, Beaumont, Roques, Fournié-Zaluski (bb0175) 1998; 37 Sato (bb0085) 2003; 10 Taylor (bb0005) 1993; 7 Hitzerd, Verbrugge, Ossenkoppele, Jansen, Peters (bb0025) 2014; 46 Surowiak, Drag, Materna, Suchocki, Grzywa, Spaczynski, Dietel, Oleksyszyn, Zabel, Lage (bb0495) 2006; 16 Mina-Osorio, Ortega (bb0280) 2005; 77 Tokuhara, Hattori, Ishida, Hirai, Higashiyama, Kodama, Miyake (bb0440) 2006; 12 Wang, Xie, Wei, Chen, Zhao, Song, Zhang, Li (bb0460) 2016; 9 Fujii, Nakajima, Aoyagi, Tsuruo (bb0075) 1996; 19 Ishii, Ogawa, Itoh, Ikenaga, Saruta (bb0295) 1994; 48 Richardson, Bringhen, Voorhees, Plesner, Mellqvist, Reeves, Paba-Prada, Zubair, Byrne, Chauhan, Anderson, Nordström, Harmenberg, Palumbo, Sonneveld (bb0575) 2020; 7 Sørensen, Abildgaard, Haldrup, Ulhøi, Kristensen, Strand, Parker, Høyer, Borre, Ørntoft (bb0465) 2013; 108 Krige, Needham, Bawden, Flores, Farmer, Miles, Stone, Callaghan, Chandler, Clark, Kirwin-Jones, Legris, Owen, Patel, Wood, Box, Laber, Odedra, Wright, Wood, Eccles, Bone, Ayscough, Drummond (bb0540) 2008; 68 Goto, Hattori, Ishii, Mizutani, Tsujimoto (bb0115) 2006; 281 Hashida, Takabayashi, Kanai, Adachi, Kondo, Kohno, Yamaoka, Miyake (bb0105) 2002; 122 Look, Ashmun, Shapiro, Peiper (bb0150) 1989; 83 Zhang, Wang, Zhang, Zhao, Zhang, Zhang (bb0430) 2015; 11 Rosenzwajg, Tailleux, Gluckman (bb0270) 2000; 95 Dong, An, Salvucci Kierstead, Storkus, Amoscato, Salter (bb0275) 1950; 164 Pinho, Reis (bb0635) 2015; 15 Gregorc, Santoro, Bennicelli, Punt, Citterio, Timmer-Bonte, Caligaris Cappio, Lambiase, Bordignon, van Herpen (bb0520) 2009; 101 Ravidà, Musante, Kreivi, Miinalainen, Byrne, Saraswat, Henry, Meleady, Clynes, Holthofer (bb0620) 2015; 87 Rahbar, Bostrom, Soderberg-Naucler (bb0300) 2006; 26 Carrascal, Silva, Ferreira, Azevedo, Ferreira, Silva, Ligeiro, Santos, Sackstein, Videira (bb0615) 2018; 1862 Mina-Osorio (bb0210) 2008; 14 Razak, Newland (bb0285) 1992; 6 Iwamoto, Deguchi, Ohta, Kiyokawa, Tsurusawa, Yamada, Takase, Fujimoto, Hanada, Hori, Horibe, Komada (bb0480) 2011; 94 Wilkes, Prescott (bb0545) 1985; 260 Larrinaga, Blanco, Sanz, Perez, Gil, Unda, Andres, Casis, Lopez (bb0500) 2012; 303 Aoyagi, Yoshida, Nakamura, Shigihara, Hamada, Takeuchi (bb0530) 1990; 43 Pereira, Cronin, Ghosh, Zhou, Agosto, Subramani, Wang, Shen, Schacke, Liang, Yang, McAulliffe, Liang, Shapiro (bb0335) 2013; 100 Murakami, Yokoyama, Kondo, Nakanishi, Kohno, Miyake (bb0110) 2005; 11 Bhagwat, Lahdenranta, Giordano, Arap, Pasqualini, Shapiro (bb0420) 2001; 97 Urade, Komatsu, Yamaoka, Fukasawa, Harada, Mima, Matsuya (bb0045) 1989; 64 Ward, Benter, Dick, Wilk (bb0250) 1990; 40 J.J. Miettinen R. Kumari G.A. Traustadottir M.-E. Huppunen P. Sergeev M.M. Majumder A. Schepsky T. Gudjonsson J. Lievonen D. Bazou P. Dowling P. O`Gorman, A. Slipicevic, P. Anttila, R. Silvennoinen, N.N. Nupponen, F. Lehmann, C.A. Heckman, Aminopeptidase expression in multiple myeloma associates with disease progression and sensitivity to melflufen Cancers 13 2021 1527. Mukhopadhyay, Barnés, Haskel, Short, Barnes, Lippard (bb0590) 2008; 19 Taylor, Yaneva, Velasco, Philip, Erdjument-Bromage, Ostrovnaya, Lilja, Bochner, Tempst (bb0040) 2014; 8 Luan, Xu (bb0245) 2007; 14 Moore, Davenport, Smith, Muralikrishnan, Dunlop, Walker, Krige, Drummond, Hooftman, Morgan, Davies (bb0065) 2009; 8 Carl-McGrath, Lendeckel, Ebert, Rocken (bb0355) 2006; 21 Wang, Niu, Jia, Cui, Han, Zhang, Liu, Bi, Liu (bb0380) 2016; 35 Dominguez, Perez-Chacon, Guillen, Munoz-Alonso, Somovilla-Crespo, Cibrian, Acosta-Iborra, Adrados, Munoz-Calleja, Cuevas, Sanchez-Madrid, Aviles, Zapata (bb0345) 2020; 13 Drag, Bogyo, Ellman, Salvesen (bb0130) 2010; 285 Sanz, Perez, Beitia, Errarte, Fernandez, Blanco, Estalella, Loizate, Irazusta, Lopez, Larrinaga (bb0490) 2015; 63 (bb0565) 2021; 2021 Schepsky, Traustadottir, Joelsson, Ingthorsson, Kricker, Bergthorsson, Asbjarnarson, Gudjonsson, Nupponen, Slipicevic, Lehmann, Gudjonsson (bb0580) 2020; 9 Wickström, Nygren, Larsson, Harmenberg, Lindberg, Sjöberg, Jerling, Lehmann, Richardson, Anderson, Chauhan, Gullbo (bb0555) 2017; 8 Joshi, Chen, Winter, Lin, Yang, Shapovalova, Smith, Liu, Li, LeBeau (bb0135) 2017; 7 Yeager, Ashmun, Williams, Cardellichio, Shapiro, Look, Holmes (bb0320) 1992; 357 Aozuka, Koizumi, Saitoh, Ueda, Sakurai, Saiki (bb0095) 2004; 216 Bertilaccio, Grioni, Sutherland, Degl'Innocenti, Freschi, Jachetti, Greenberg, Corti, Bellone (bb0585) 2008; 68 Riemann, Kehlen, Langner (bb0160) 1999; 20 Xu, Wellner, Scheinberg (bb0235) 1995; 208 Ikeda, Nakajima, Tokuhara, Hattori, Sho, Kanehiro, Miyake (bb0455) 2003; 9 Kenny, Maroux (bb0625) 1982; 62 Wickstrom, Larsson, Nygren, Gullbo (bb0305) 2011; 102 Atkinson, Armistead, Mathias, Sandeu, Tao, Borhani-Dizaji, Tarimo, Morlais, Dinglasan, Borg (bb0330) 2015; 22 Rutenburg, Goldbarg, Pineda (bb0050) 1958; 259 Mishima, Matsumoto-Mishima, Terui, Katsuyama, Yamada, Mori, Ishizaka, Ikeda, Watanabe, Mizunuma, Hayasawa, Hatake (bb0360) 2002; I Grdisa, Vitale (bb0015) 1991; 23 Dan, Tani, Hase, Shimizu, Tamiya, Biraa, Huang, Yanagawa, Sone (bb0030) 2003; 23 Fontijn, Duyndam, van Berkel, Yuana, Shapiro, Pinedo, Broxterman, Boven (bb0395) 2006; 94 Gregorc, Zucali, Santoro, Ceresoli, Citterio, De Pas, Zilembo, De Vincenzo, Simonelli, Rossoni, Spreafico, Vigano, Fontana, De Braud, Bajetta, Caligaris-Cappio, Bruzzi, Lambiase, Bordignon (bb0425) 2010; 28 Ashmun, Shapiro, Look (bb0170) 1992; 79 Grujić, Renko (bb0385) 2002; 182 Ashmun, Look (bb0200) 1990; 75 Luan, Ma, Sui, Wang, Feng, Liu, Jing, Wang, Li, Fang, W. (bb0525) 2011; 7 Fukasawa, Fukasawa, Harada, Hirose, Izumi, Shimizu (bb0120) 1999; 339 Wentworth, Holmes (bb0610) 2001; 75 Banks, Pineda, Goldbarg, Rutenburg (bb0060) 1960; 263 Selvakumar, Lakshmikuttyamma, Dimmock, Sharma (bb0125) 2006; 1765 Sekine, Fujii, Abe (bb0365) 1999; 13 Gong, Shi, Li, Ma (bb0100) 2016; 7 Danziger (10.1016/j.bbcan.2021.188641_bb0260) 2008; 13 Mina-Osorio (10.1016/j.bbcan.2021.188641_bb0210) 2008; 14 Surowiak (10.1016/j.bbcan.2021.188641_bb0495) 2006; 16 Richardson (10.1016/j.bbcan.2021.188641_bb0575) 2020; 7 Ashmun (10.1016/j.bbcan.2021.188641_bb0170) 1992; 79 Murakami (10.1016/j.bbcan.2021.188641_bb0110) 2005; 11 Wickstrom (10.1016/j.bbcan.2021.188641_bb0515) 2010; 79 Gong (10.1016/j.bbcan.2021.188641_bb0100) 2016; 7 Bhagwat (10.1016/j.bbcan.2021.188641_bb0420) 2001; 97 Ito (10.1016/j.bbcan.2021.188641_bb0435) 2009; 57 Gregorc (10.1016/j.bbcan.2021.188641_bb0595) 2018; 19 (10.1016/j.bbcan.2021.188641_bb0145) 1980; 599 Look (10.1016/j.bbcan.2021.188641_bb0150) 1989; 83 Carl-McGrath (10.1016/j.bbcan.2021.188641_bb0355) 2006; 21 Wickström (10.1016/j.bbcan.2021.188641_bb0555) 2017; 8 Helenius (10.1016/j.bbcan.2021.188641_bb0630) 2001; 291 Wentworth (10.1016/j.bbcan.2021.188641_bb0610) 2001; 75 Gregorc (10.1016/j.bbcan.2021.188641_bb0520) 2009; 101 Saiki (10.1016/j.bbcan.2021.188641_bb0405) 1993; 54 Mina-Osorio (10.1016/j.bbcan.2021.188641_bb0280) 2005; 77 Dominguez (10.1016/j.bbcan.2021.188641_bb0345) 2020; 13 Scornik (10.1016/j.bbcan.2021.188641_bb0535) 2001; 2 Wickstrom (10.1016/j.bbcan.2021.188641_bb0560) 2008; 26 Mishima (10.1016/j.bbcan.2021.188641_bb0360) 2002; I Rutenburg (10.1016/j.bbcan.2021.188641_bb0050) 1958; 259 Carrascal (10.1016/j.bbcan.2021.188641_bb0615) 2018; 1862 Grdisa (10.1016/j.bbcan.2021.188641_bb0015) 1991; 23 Hanahan (10.1016/j.bbcan.2021.188641_bb0350) 2011; 144 Terauchi (10.1016/j.bbcan.2021.188641_bb0370) 2007; 7 Nakase (10.1016/j.bbcan.2021.188641_bb0290) 1996; 105 Fukasawa (10.1016/j.bbcan.2021.188641_bb0120) 1999; 339 Kehlen (10.1016/j.bbcan.2021.188641_bb0505) 2003; 63 Moore (10.1016/j.bbcan.2021.188641_bb0065) 2009; 8 Gros (10.1016/j.bbcan.2021.188641_bb0195) 1985; 24 Atkinson (10.1016/j.bbcan.2021.188641_bb0330) 2015; 22 Tokuhara (10.1016/j.bbcan.2021.188641_bb0440) 2006; 12 Wong (10.1016/j.bbcan.2021.188641_bb0165) 2012; 287 Sanz (10.1016/j.bbcan.2021.188641_bb0490) 2015; 63 Luciani (10.1016/j.bbcan.2021.188641_bb0175) 1998; 37 Pfleiderer (10.1016/j.bbcan.2021.188641_bb0140) 1963; 339 Dixon (10.1016/j.bbcan.2021.188641_bb0205) 1994; 47 Ikeda (10.1016/j.bbcan.2021.188641_bb0455) 2003; 9 Hooper (10.1016/j.bbcan.2021.188641_bb0185) 1994; 354 (10.1016/j.bbcan.2021.188641_bb0325) 2007 Reaux (10.1016/j.bbcan.2021.188641_bb0255) 1999; 69 Pineda (10.1016/j.bbcan.2021.188641_bb0055) 1960; 38 Ashmun (10.1016/j.bbcan.2021.188641_bb0200) 1990; 75 Schreiber (10.1016/j.bbcan.2021.188641_bb0080) 2018; I Wilkes (10.1016/j.bbcan.2021.188641_bb0545) 1985; 260 Hashida (10.1016/j.bbcan.2021.188641_bb0105) 2002; 122 Larrinaga (10.1016/j.bbcan.2021.188641_bb0500) 2012; 303 Krige (10.1016/j.bbcan.2021.188641_bb0540) 2008; 68 Matteo (10.1016/j.bbcan.2021.188641_bb0605) 2011; 59 10.1016/j.bbcan.2021.188641_bb0570 Luan (10.1016/j.bbcan.2021.188641_bb0245) 2007; 14 Bertilaccio (10.1016/j.bbcan.2021.188641_bb0585) 2008; 68 Lorusso (10.1016/j.bbcan.2021.188641_bb0600) 2012; 107 Pasqualini (10.1016/j.bbcan.2021.188641_bb0220) 2000; 60 Mukhopadhyay (10.1016/j.bbcan.2021.188641_bb0590) 2008; 19 Marchio (10.1016/j.bbcan.2021.188641_bb0090) 2004; 5 Sato (10.1016/j.bbcan.2021.188641_bb0085) 2003; 10 Oconnell (10.1016/j.bbcan.2021.188641_bb0155) 1991; 266 Curnis (10.1016/j.bbcan.2021.188641_bb0225) 2002; 62 Goto (10.1016/j.bbcan.2021.188641_bb0115) 2006; 281 Selvakumar (10.1016/j.bbcan.2021.188641_bb0125) 2006; 1765 Taylor (10.1016/j.bbcan.2021.188641_bb0005) 1993; 7 Fujii (10.1016/j.bbcan.2021.188641_bb0075) 1996; 19 Wang (10.1016/j.bbcan.2021.188641_bb0460) 2016; 9 Sekine (10.1016/j.bbcan.2021.188641_bb0365) 1999; 13 Luan (10.1016/j.bbcan.2021.188641_bb0525) 2011; 7 Rangel (10.1016/j.bbcan.2021.188641_bb0410) 2007; 104 Xu (10.1016/j.bbcan.2021.188641_bb0235) 1995; 208 Iwamoto (10.1016/j.bbcan.2021.188641_bb0480) 2011; 94 Hitzerd (10.1016/j.bbcan.2021.188641_bb0025) 2014; 46 Ranogajec (10.1016/j.bbcan.2021.188641_bb0450) 2012; 29 Nanus (10.1016/j.bbcan.2021.188641_bb0020) 2003; 9 Riemann (10.1016/j.bbcan.2021.188641_bb0160) 1999; 20 (10.1016/j.bbcan.2021.188641_bb0180) 2012; 109 Otsuki (10.1016/j.bbcan.2021.188641_bb0485) 2018; 51 Aozuka (10.1016/j.bbcan.2021.188641_bb0095) 2004; 216 Rosenzwajg (10.1016/j.bbcan.2021.188641_bb0270) 2000; 95 Urade (10.1016/j.bbcan.2021.188641_bb0045) 1989; 64 Rahbar (10.1016/j.bbcan.2021.188641_bb0300) 2006; 26 Ward (10.1016/j.bbcan.2021.188641_bb0250) 1990; 40 Grujić (10.1016/j.bbcan.2021.188641_bb0385) 2002; 182 Zhang (10.1016/j.bbcan.2021.188641_bb0430) 2015; 11 Drag (10.1016/j.bbcan.2021.188641_bb0130) 2010; 285 Guzman-Rojas (10.1016/j.bbcan.2021.188641_bb0400) 2012; 109 Söderberg (10.1016/j.bbcan.2021.188641_bb0315) 1993; 67 Yeager (10.1016/j.bbcan.2021.188641_bb0320) 1992; 357 Aoyagi (10.1016/j.bbcan.2021.188641_bb0530) 1990; 43 Bauvois (10.1016/j.bbcan.2021.188641_bb0415) 2006; 26 Kenny (10.1016/j.bbcan.2021.188641_bb0625) 1982; 62 (10.1016/j.bbcan.2021.188641_bb0565) 2021; 2021 Fontijn (10.1016/j.bbcan.2021.188641_bb0395) 2006; 94 Ravidà (10.1016/j.bbcan.2021.188641_bb0620) 2015; 87 Kakinuma (10.1016/j.bbcan.2021.188641_bb0215) 2009; 51 Lendeckel (10.1016/j.bbcan.2021.188641_bb0265) 2000; 477 Carl-McGrath (10.1016/j.bbcan.2021.188641_bb0390) 2004; 25 Wang (10.1016/j.bbcan.2021.188641_bb0380) 2016; 35 Helene (10.1016/j.bbcan.2021.188641_bb0190) 1991; 196 Dong (10.1016/j.bbcan.2021.188641_bb0275) 1950; 164 Pang (10.1016/j.bbcan.2021.188641_bb0310) 2016; 7 Schmidt (10.1016/j.bbcan.2021.188641_bb0445) 2017; 12 Sørensen (10.1016/j.bbcan.2021.188641_bb0465) 2013; 108 Taylor (10.1016/j.bbcan.2021.188641_bb0040) 2014; 8 Amin (10.1016/j.bbcan.2021.188641_bb0340) 2018; 61 Pereira (10.1016/j.bbcan.2021.188641_bb0335) 2013; 100 Röcken (10.1016/j.bbcan.2021.188641_bb0470) 2005; 58 Razak (10.1016/j.bbcan.2021.188641_bb0285) 1992; 6 Pinho (10.1016/j.bbcan.2021.188641_bb0635) 2015; 15 Liu (10.1016/j.bbcan.2021.188641_bb0375) 2015; 33 Joshi (10.1016/j.bbcan.2021.188641_bb0135) 2017; 7 Shapiro (10.1016/j.bbcan.2021.188641_bb0230) 1991; 266 Schepsky (10.1016/j.bbcan.2021.188641_bb0580) 2020; 9 Ishii (10.1016/j.bbcan.2021.188641_bb0295) 1994; 48 Yoneda (10.1016/j.bbcan.2021.188641_bb0070) 1992; 10 van Hensbergen (10.1016/j.bbcan.2021.188641_bb0035) 2002; 8 Martinez (10.1016/j.bbcan.2021.188641_bb0010) 1999; 45 Banks (10.1016/j.bbcan.2021.188641_bb0060) 1960; 263 Gregorc (10.1016/j.bbcan.2021.188641_bb0425) 2010; 28 Sobol-Milejska (10.1016/j.bbcan.2021.188641_bb0475) 2013; 98 Kawamura (10.1016/j.bbcan.2021.188641_bb0550) 2007; 54 Wickstrom (10.1016/j.bbcan.2021.188641_bb0305) 2011; 102 Schmitt (10.1016/j.bbcan.2021.188641_bb0510) 2013; 21 Dan (10.1016/j.bbcan.2021.188641_bb0030) 2003; 23 Turner (10.1016/j.bbcan.2021.188641_bb0240) 2013 |
| References_xml | – volume: 23 start-page: 339 year: 1991 end-page: 345 ident: bb0015 article-title: Types and localization of aminopeptidases in different human blood-cells publication-title: Int. J. Biochem. – volume: 77 start-page: 1008 year: 2005 end-page: 1017 ident: bb0280 article-title: Aminopeptidase N (CD13) functionally interacts with FcgammaRs in human monocytes publication-title: J. Leukoc. Biol. – volume: 477 start-page: 1 year: 2000 end-page: 24 ident: bb0265 article-title: Review: the role of membrane peptidases in immune functions publication-title: Adv. Exp. Med. Biol. – volume: 9 start-page: 6726 year: 2020 end-page: 6738 ident: bb0580 article-title: Melflufen, a peptide-conjugated alkylator, is an efficient anti-neo-plastic drug in breast cancer cell lines publication-title: Cancer Med. – volume: 57 start-page: 591 year: 2009 end-page: 598 ident: bb0435 article-title: Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer publication-title: Gen. Thorac. Cardiovasc. Surg. – volume: 13 start-page: 293 year: 2008 end-page: 298 ident: bb0260 article-title: Aminopeptidase N in arterial hypertension publication-title: Heart Fail. Rev. – volume: 8 start-page: 3747 year: 2002 end-page: 3754 ident: bb0035 article-title: Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid publication-title: clinical cancer research – volume: 37 start-page: 686 year: 1998 end-page: 692 ident: bb0175 article-title: Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action publication-title: Biochemistry – volume: 87 start-page: 963 year: 2015 end-page: 974 ident: bb0620 article-title: Glycosylation patterns of kidney proteins differ in rat diabetic nephropathy publication-title: Kidney Int. – volume: 79 start-page: 3344 year: 1992 end-page: 3349 ident: bb0170 article-title: Deletion of the zinc-binding motif of Cd13/Aminopeptidase-N molecules results in loss of epitopes that mediate binding of inhibitory antibodies publication-title: Blood – volume: 94 start-page: 1627 year: 2006 end-page: 1636 ident: bb0395 article-title: CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells publication-title: Br. J. Cancer – volume: 266 start-page: 11999 year: 1991 end-page: 12007 ident: bb0230 article-title: Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells publication-title: J. Biol. Chem. – volume: 100 start-page: 74 year: 2013 end-page: 83 ident: bb0335 article-title: CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in mice publication-title: Cardiovasc. Res. – volume: 7 start-page: e395 year: 2020 end-page: e407 ident: bb0575 article-title: Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study publication-title: Lancet Haematol. – volume: 54 start-page: 36 year: 2007 end-page: 40 ident: bb0550 article-title: Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma publication-title: Hepato-Gastroenterology – volume: 8 start-page: 317 year: 2014 end-page: 326 ident: bb0040 article-title: Aminopeptidase activities as prospective urinary biomarkers for bladder cancer publication-title: Proteom. Clin. Appl. – volume: 266 start-page: 4593 year: 1991 end-page: 4597 ident: bb0155 – volume: 196 start-page: 385 year: 1991 end-page: 393 ident: bb0190 article-title: Functional residues at the active-site of aminopeptidase-N publication-title: Eur. J. Biochem. – volume: 14 start-page: 639 year: 2007 end-page: 647 ident: bb0245 article-title: The structure and main functions of aminopeptidase N publication-title: Curr. Med. Chem. – reference: J.J. Miettinen R. Kumari G.A. Traustadottir M.-E. Huppunen P. Sergeev M.M. Majumder A. Schepsky T. Gudjonsson J. Lievonen D. Bazou P. Dowling P. O`Gorman, A. Slipicevic, P. Anttila, R. Silvennoinen, N.N. Nupponen, F. Lehmann, C.A. Heckman, Aminopeptidase expression in multiple myeloma associates with disease progression and sensitivity to melflufen Cancers 13 2021 1527. – volume: 1862 start-page: 2069 year: 2018 end-page: 2080 ident: bb0615 article-title: A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer publication-title: Biochim. Biophys. Acta Gen. Subj. – volume: 46 start-page: 793 year: 2014 end-page: 808 ident: bb0025 article-title: Positioning of aminopeptidase inhibitors in next generation cancer therapy publication-title: Amino Acids – volume: 69 start-page: 370 year: 1999 end-page: 376 ident: bb0255 article-title: PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III publication-title: Neuroendocrinology – volume: 7 start-page: 32 year: 2011 end-page: 36 ident: bb0525 article-title: Xu, LYP3, a new bestatin derivative for aminopeptidase N inhibition publication-title: Med. Chem. – volume: 79 start-page: 1281 year: 2010 end-page: 1290 ident: bb0515 article-title: The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan publication-title: Biochem. Pharmacol. – volume: 60 start-page: 722 year: 2000 end-page: 727 ident: bb0220 article-title: Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis publication-title: Cancer Res. – volume: 9 start-page: 1503 year: 2003 end-page: 1508 ident: bb0455 article-title: Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma publication-title: Clin. Cancer Res. – volume: 68 start-page: 6669 year: 2008 end-page: 6679 ident: bb0540 article-title: CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells publication-title: Cancer Res. – volume: 62 start-page: 91 year: 1982 end-page: 128 ident: bb0625 article-title: Topology of microvillar membrance hydrolases of kidney and intestine publication-title: Physiol. Rev. – volume: 48 start-page: 174 year: 1994 end-page: 182 ident: bb0295 article-title: Diagnostic significance of urinary enzymes for diabetes mellitus and hypertension publication-title: Enzyme Protein – volume: 107 start-page: 37 year: 2012 end-page: 42 ident: bb0600 article-title: Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients publication-title: Br. J. Cancer – volume: 19 start-page: 799 year: 2018 end-page: 811 ident: bb0595 article-title: NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial, the lancet publication-title: Oncology – volume: 281 start-page: 23503 year: 2006 end-page: 23513 ident: bb0115 article-title: Enzymatic properties of human aminopeptidase a: regulationofitsenzymaticactivitybycalciumandangiostensin IV publication-title: J. Biol. Chem. – volume: 164 start-page: 129 year: 1950 end-page: 135 ident: bb0275 article-title: Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells publication-title: J.Immunol. (Baltimore, Md.) – volume: 98 start-page: 331 year: 2013 end-page: 336 ident: bb0475 article-title: Expression of myeloid antigens on lymphoblast surface in childhood acute lymphoblastic leukemia at diagnosis and its effect on early response to treatment: a preliminary report publication-title: Int. J. Hematol. – volume: 23 start-page: 271 year: 2003 end-page: 276 ident: bb0030 article-title: CD13/aminopeptidase N in collagen vascular diseases publication-title: Rheumatol. Int. – volume: 33 start-page: 1372 year: 2015 end-page: 1380 ident: bb0375 article-title: Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated publication-title: Oncol. Rep. – volume: 28 start-page: 2604 year: 2010 end-page: 2611 ident: bb0425 article-title: Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, previously treated patients with malignant pleural mesothelioma publication-title: J. Clin. Oncol. – volume: 357 start-page: 420 year: 1992 end-page: 422 ident: bb0320 article-title: Human aminopeptidase N is a receptor for human coronavirus 229E publication-title: Nature – volume: 2 start-page: 67 year: 2001 end-page: 85 ident: bb0535 article-title: Bestatin as an experimental tool in mammals publication-title: Curr. Drug Metab. – volume: 45 start-page: 1797 year: 1999 end-page: 1802 ident: bb0010 article-title: Aminopeptidase activities in breast cancer tissue publication-title: Clin. Chem. – volume: 12 year: 2017 ident: bb0445 article-title: Potential therapeutic impact of CD13 expression in non-small cell lung cancer publication-title: PLoS One – volume: 59 start-page: 47 year: 2011 end-page: 59 ident: bb0605 article-title: Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues publication-title: J. Histochem. Cytochem. – volume: 40 start-page: 1725 year: 1990 end-page: 1732 ident: bb0250 article-title: Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M publication-title: Biochem. Pharmacol. – volume: 144 start-page: 646 year: 2011 end-page: 674 ident: bb0350 article-title: Hallmarks of cancer: the next generation publication-title: Cell – volume: 58 start-page: 1069 year: 2005 end-page: 1075 ident: bb0470 article-title: Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma publication-title: J. Clin. Pathol. – volume: 7 start-page: 1424 year: 2017 ident: bb0135 article-title: The rational design of therapeutic peptides for aminopeptidase N using a substrate-based approach publication-title: Sci. Rep. – volume: 94 start-page: 185 year: 2011 end-page: 192 ident: bb0480 article-title: Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese pediatric leukemia/lymphoma study group publication-title: Int. J. Hematol. – volume: 7 start-page: 788 year: 2016 end-page: 792 ident: bb0100 article-title: Leucine aminopeptidase may contribute to the intrinsic resistance of cancer cells toward cisplatin as revealed by an ultrasensitive fluorescent probe publication-title: Chem. Sci. – volume: 303 start-page: F1584 year: 2012 end-page: F1591 ident: bb0500 article-title: The impact of peptidase activity on clear cell renal cell carcinoma survival publication-title: Am. J. Physiol. – volume: 14 start-page: 361 year: 2008 end-page: 371 ident: bb0210 article-title: The moonlighting enzyme CD13: old and new functions to target publication-title: Trends Mol. Med. – volume: 75 start-page: 9741 year: 2001 end-page: 9752 ident: bb0610 article-title: Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation publication-title: J. Virol. – volume: 105 start-page: 761 year: 1996 end-page: 768 ident: bb0290 article-title: Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms publication-title: Am. J. Clin. Pathol. – volume: 35 start-page: 2121 year: 2016 end-page: 2130 ident: bb0380 article-title: Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells publication-title: Oncol. Rep. – volume: 12 start-page: 3971 year: 2006 ident: bb0440 article-title: Clinical significance of aminopeptidase N in non-small cell lung cancer publication-title: Clin. Cancer Res. – volume: 1765 start-page: 148 year: 2006 end-page: 154 ident: bb0125 article-title: Methionine aminopeptidase 2 and cancer publication-title: Biochim. Biophys. Acta – volume: 15 start-page: 540 year: 2015 end-page: 555 ident: bb0635 article-title: Glycosylation in cancer: mechanisms and clinical implications publication-title: Nat. Rev. Cancer – volume: 97 start-page: 652 year: 2001 end-page: 659 ident: bb0420 article-title: CD13/APN is activated by angiogenic signals and is essential for capillary tube formation publication-title: Blood – volume: 95 start-page: 453 year: 2000 end-page: 460 ident: bb0270 article-title: CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34+ cells publication-title: Blood – volume: 21 start-page: 2135 year: 2013 end-page: 2144 ident: bb0510 article-title: Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy publication-title: Bioorg. Med. Chem. – volume: 2021 year: 2021 ident: bb0565 article-title: FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma – volume: 339 start-page: 186 year: 1963 end-page: 189 ident: bb0140 article-title: Isolation of an aminopeptidase from kidney particles publication-title: Biochem. Z. – volume: 11 start-page: 8674 year: 2005 end-page: 8679 ident: bb0110 article-title: Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer publication-title: clinical cancer research – volume: 8 start-page: 762 year: 2009 end-page: 770 ident: bb0065 article-title: Aminopeptidase inhibition as a targeted treatment strategy in myeloma publication-title: Mol. Cancer Ther. – volume: 47 start-page: 43 year: 1994 end-page: 47 ident: bb0205 article-title: Expression of aminopeptidase-N (Cd-13) in normal-tissues and malignant neoplasms of epithelial and lymphoid origin publication-title: J. Clin. Pathol. – volume: 13 start-page: 729 year: 1999 end-page: 734 ident: bb0365 article-title: Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines publication-title: Leukemia – volume: 108 start-page: 420 year: 2013 end-page: 428 ident: bb0465 article-title: Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer publication-title: Br. J. Cancer – volume: 101 start-page: 219 year: 2009 end-page: 224 ident: bb0520 article-title: Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours publication-title: Br. J. Cancer – volume: 63 start-page: 8500 year: 2003 end-page: 8506 ident: bb0505 article-title: Biological significance of aminopeptidase N/CD13 in thyroid carcinomas publication-title: Cancer Res. – volume: 63 start-page: 740 year: 2015 end-page: 746 ident: bb0490 article-title: Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients publication-title: J. Investig. Med. – volume: 122 start-page: 376 year: 2002 end-page: 386 ident: bb0105 article-title: Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer publication-title: Gastroenterology – volume: 29 start-page: 561 year: 2012 end-page: 569 ident: bb0450 article-title: Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients publication-title: Med.Oncol. – volume: 9 start-page: 22034 year: 2016 end-page: 22040 ident: bb0460 article-title: Relation between the expression of aminopeptidase N(APN)/CD13 and the clinical significance in osteosarcomas publication-title: Int. J. Clin. Exp. Med. – volume: 13 year: 2020 ident: bb0345 article-title: CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110 publication-title: J. Hematol. Oncol. – volume: 26 start-page: 88 year: 2006 end-page: 130 ident: bb0415 article-title: Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects publication-title: Med. Res. Rev. – volume: 51 start-page: 1701610 year: 2018 ident: bb0485 article-title: Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma publication-title: Eur. Respir. J. – volume: 20 start-page: 83 year: 1999 end-page: 88 ident: bb0160 article-title: CD13 - not just a marker in leukemia typing publication-title: Immunol. Today – volume: 7 start-page: 77854 year: 2016 end-page: 77864 ident: bb0310 article-title: Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer publication-title: Oncotarget – volume: 43 start-page: 143 year: 1990 end-page: 148 ident: bb0530 article-title: Probestin, a new inhibitor of aminopeptidase-M, produced by streptomyces-azureus Mh663-2f6.1. Taxonomy, production, isolation, physicochemical properties and biological-activities publication-title: J. Antibiot. – volume: 67 start-page: 6576 year: 1993 end-page: 6585 ident: bb0315 article-title: CD13 (human aminopeptidase N) mediates human cytomegalovirus infection publication-title: J. Virol. – volume: 7 start-page: 140 year: 2007 ident: bb0370 article-title: Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells publication-title: BMC Cancer – volume: 291 start-page: 2364 year: 2001 end-page: 2369 ident: bb0630 article-title: Intracellular functions of N-linked glycans publication-title: Science – volume: 9 start-page: 6307 year: 2003 end-page: 6309 ident: bb0020 article-title: Of peptides and peptidases: the role of cell surface peptidases in cancer publication-title: Clin. Cancer Res. – volume: 109 start-page: 17966 year: 2012 end-page: 17971 ident: bb0180 article-title: Structural basis for multifunctional roles of mammalian aminopeptidase N publication-title: Proc. Natl. Acad. Sci. U. S. A – volume: 339 start-page: 497 year: 1999 end-page: 502 ident: bb0120 article-title: Aminopeptidase B is structurally related to leukotriene-A4 hydrolase but is not a bifunctional enzyme with epoxide hydrolase activity publication-title: Biochem. J. – volume: 287 start-page: 36804 year: 2012 end-page: 36813 ident: bb0165 article-title: The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing publication-title: J. Biol. Chem. – volume: 10 start-page: 287 year: 2003 end-page: 290 ident: bb0085 article-title: Aminopeptidases and angiogenesis publication-title: Endothelium – volume: 259 start-page: 469 year: 1958 end-page: 472 ident: bb0050 article-title: Leucine aminopeptidase activity; observations in patients with cancer of the pancreas and other diseases publication-title: N. Engl. J. Med. – volume: 5 start-page: 151 year: 2004 end-page: 162 ident: bb0090 article-title: Aminopeptidase a is a functional target in angiogenic blood vessels publication-title: Cancer Cell – volume: 19 start-page: 6 year: 1996 end-page: 10 ident: bb0075 article-title: Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors publication-title: Biol. Pharm. Bull. – year: 2007 ident: bb0325 article-title: Early events in human cytomegalovirus infection publication-title: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis – volume: 102 start-page: 501 year: 2011 end-page: 508 ident: bb0305 article-title: Aminopeptidase N (CD13) as a target for cancer chemotherapy publication-title: Cancer Sci. – volume: 61 start-page: 6468 year: 2018 end-page: 6490 ident: bb0340 article-title: Design of Aminopeptidase N Inhibitors as anti-cancer agents publication-title: J. Med. Chem. – volume: 19 start-page: 39 year: 2008 end-page: 49 ident: bb0590 article-title: Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature publication-title: Bioconjug. Chem. – volume: 21 start-page: 1339 year: 2006 end-page: 1353 ident: bb0355 article-title: Ectopeptidases in tumour biology: a review publication-title: Histol. Histopathol. – volume: 25 start-page: 1223 year: 2004 end-page: 1232 ident: bb0390 article-title: The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer publication-title: Int. J. Oncol. – volume: 109 start-page: 1637 year: 2012 end-page: 1642 ident: bb0400 article-title: Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 83 start-page: 1299 year: 1989 end-page: 1307 ident: bb0150 article-title: Human myeloid plasma-membrane glycoprotein Cd13 (Gp150) is identical to aminopeptidase-N publication-title: J. Clin. Invest. – volume: 22 start-page: 532 year: 2015 end-page: 539 ident: bb0330 article-title: The anopheles-midgut APN1 structure reveals a new malaria transmission-blocking vaccine epitope publication-title: Nat. Struct. Mol. Biol. – volume: 51 start-page: 127 year: 2009 end-page: 138 ident: bb0215 article-title: Analyses of cell surface molecules on hepatic stem/progenitor cells in mouse fetal liver publication-title: J. Hepatol. – volume: 26 start-page: 195 year: 2008 end-page: 204 ident: bb0560 article-title: The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro publication-title: Investig. New Drugs – volume: 285 start-page: 3310 year: 2010 end-page: 3318 ident: bb0130 article-title: Aminopeptidase fingerprints, an integrated approach for identification of good substrates and optimal inhibitors publication-title: J. Biol. Chem. – volume: I year: 2018 ident: bb0080 article-title: Molecular imaging of aminopeptidase N in cancer and angiogenesis publication-title: Contrast Media Mol. – volume: I start-page: 1020 year: 2002 end-page: 1028 ident: bb0360 article-title: Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells publication-title: J. Natl. Cancer – volume: 7 start-page: 290 year: 1993 end-page: 298 ident: bb0005 article-title: Aminopeptidases - structure and function publication-title: FASEB J. – volume: 6 start-page: 243 year: 1992 end-page: 250 ident: bb0285 article-title: The significance of aminopeptidases and haematopoietic cell differentiation publication-title: Blood Rev. – volume: 38 start-page: 698 year: 1960 end-page: 712 ident: bb0055 article-title: Serum leucine aminopeptidase in pancreatic and hepatobiliary diseases publication-title: Gastroenterology – volume: 75 start-page: 462 year: 1990 end-page: 469 ident: bb0200 article-title: Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells publication-title: Blood – volume: 11 start-page: 223 year: 2015 end-page: 228 ident: bb0430 article-title: Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer publication-title: J. Cancer Res. Ther. – volume: 16 start-page: 1783 year: 2006 end-page: 1788 ident: bb0495 article-title: Expression of aminopeptidase N/CD13 in human ovarian cancers publication-title: Int. J. Gynecol. Cancer – start-page: 397 year: 2013 end-page: 403 ident: bb0240 article-title: Chapter 79 - aminopeptidase N publication-title: Handbook of Proteolytic Enzymes (Third Edition) – volume: 68 start-page: 1105 year: 2008 end-page: 1115 ident: bb0585 article-title: Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer publication-title: Prostate – volume: 216 start-page: 35 year: 2004 end-page: 42 ident: bb0095 article-title: Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice publication-title: Cancer Lett. – volume: 26 start-page: 155 year: 2006 end-page: 164 ident: bb0300 article-title: Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease publication-title: J. Autoimmun. – volume: 208 start-page: 664 year: 1995 end-page: 674 ident: bb0235 article-title: Substance P and bradykinin are natural inhibitors of CD13/Aminopeptidase N publication-title: Biochem. Biophys. Res. Commun. – volume: 62 start-page: 867 year: 2002 end-page: 874 ident: bb0225 article-title: Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells publication-title: Cancer Res. – volume: 104 start-page: 4588 year: 2007 end-page: 4593 ident: bb0410 article-title: Impaired angiogenesis in aminopeptidase N-null mice publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 599 start-page: 448 year: 1980 end-page: 463 ident: bb0145 article-title: Rabbit intestinal aminopeptidase N. Purification and molecular properties publication-title: Biochim Biophys Acta – volume: 54 start-page: 137 year: 1993 end-page: 143 ident: bb0405 article-title: Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation publication-title: Int. J. Cancer – volume: 260 start-page: 3154 year: 1985 end-page: 3162 ident: bb0545 article-title: The slow, tight-binding of bestatin and amastatin to aminopeptidases publication-title: J. Biol. Chem. – volume: 354 start-page: 1 year: 1994 end-page: 6 ident: bb0185 article-title: Families of zinc metalloproteases publication-title: FEBS Lett. – volume: 24 start-page: 2179 year: 1985 end-page: 2185 ident: bb0195 article-title: Identification of aminopeptidase-M as an enkephalin-inactivating enzyme in rat cerebral membranes publication-title: Biochemistry – volume: 263 start-page: 1277 year: 1960 end-page: 1281 ident: bb0060 article-title: Clinical value of serum leucine aminopeptidase determinations publication-title: N. Engl. J. Med. – volume: 64 start-page: 1274 year: 1989 end-page: 1280 ident: bb0045 article-title: Serum dipeptidyl peptidase activities as a possible marker of oral-cancer publication-title: Cancer – volume: 182 start-page: 113 year: 2002 end-page: 119 ident: bb0385 article-title: Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions publication-title: Cancer Lett. – volume: 8 start-page: 66641 year: 2017 end-page: 66655 ident: bb0555 article-title: Melflufen - a peptidase-potentiated alkylating agent in clinical trials publication-title: Oncotarget – volume: 10 start-page: 49 year: 1992 end-page: 59 ident: bb0070 publication-title: Clin. Exp. Metastas. – volume: 14 start-page: 639 year: 2007 ident: 10.1016/j.bbcan.2021.188641_bb0245 article-title: The structure and main functions of aminopeptidase N publication-title: Curr. Med. Chem. doi: 10.2174/092986707780059571 – volume: 47 start-page: 43 year: 1994 ident: 10.1016/j.bbcan.2021.188641_bb0205 article-title: Expression of aminopeptidase-N (Cd-13) in normal-tissues and malignant neoplasms of epithelial and lymphoid origin publication-title: J. Clin. Pathol. doi: 10.1136/jcp.47.1.43 – volume: 339 start-page: 497 year: 1999 ident: 10.1016/j.bbcan.2021.188641_bb0120 article-title: Aminopeptidase B is structurally related to leukotriene-A4 hydrolase but is not a bifunctional enzyme with epoxide hydrolase activity publication-title: Biochem. J. doi: 10.1042/bj3390497 – volume: 13 year: 2020 ident: 10.1016/j.bbcan.2021.188641_bb0345 article-title: CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110 publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-020-00865-7 – volume: 20 start-page: 83 year: 1999 ident: 10.1016/j.bbcan.2021.188641_bb0160 article-title: CD13 - not just a marker in leukemia typing publication-title: Immunol. Today doi: 10.1016/S0167-5699(98)01398-X – volume: 10 start-page: 49 year: 1992 ident: 10.1016/j.bbcan.2021.188641_bb0070 publication-title: Clin. Exp. Metastas. doi: 10.1007/BF00163576 – volume: 60 start-page: 722 year: 2000 ident: 10.1016/j.bbcan.2021.188641_bb0220 article-title: Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis publication-title: Cancer Res. – volume: 144 start-page: 646 year: 2011 ident: 10.1016/j.bbcan.2021.188641_bb0350 article-title: Hallmarks of cancer: the next generation publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 10 start-page: 287 year: 2003 ident: 10.1016/j.bbcan.2021.188641_bb0085 article-title: Aminopeptidases and angiogenesis publication-title: Endothelium doi: 10.1080/10623320390272334 – volume: 12 year: 2017 ident: 10.1016/j.bbcan.2021.188641_bb0445 article-title: Potential therapeutic impact of CD13 expression in non-small cell lung cancer publication-title: PLoS One – volume: 7 start-page: 788 year: 2016 ident: 10.1016/j.bbcan.2021.188641_bb0100 article-title: Leucine aminopeptidase may contribute to the intrinsic resistance of cancer cells toward cisplatin as revealed by an ultrasensitive fluorescent probe publication-title: Chem. Sci. doi: 10.1039/C5SC03600C – volume: 75 start-page: 9741 year: 2001 ident: 10.1016/j.bbcan.2021.188641_bb0610 article-title: Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation publication-title: J. Virol. doi: 10.1128/JVI.75.20.9741-9752.2001 – volume: 83 start-page: 1299 year: 1989 ident: 10.1016/j.bbcan.2021.188641_bb0150 article-title: Human myeloid plasma-membrane glycoprotein Cd13 (Gp150) is identical to aminopeptidase-N publication-title: J. Clin. Invest. doi: 10.1172/JCI114015 – volume: 7 start-page: 140 year: 2007 ident: 10.1016/j.bbcan.2021.188641_bb0370 article-title: Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells publication-title: BMC Cancer doi: 10.1186/1471-2407-7-140 – volume: 26 start-page: 155 year: 2006 ident: 10.1016/j.bbcan.2021.188641_bb0300 article-title: Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2006.02.003 – volume: 21 start-page: 1339 year: 2006 ident: 10.1016/j.bbcan.2021.188641_bb0355 article-title: Ectopeptidases in tumour biology: a review publication-title: Histol. Histopathol. – volume: 22 start-page: 532 year: 2015 ident: 10.1016/j.bbcan.2021.188641_bb0330 article-title: The anopheles-midgut APN1 structure reveals a new malaria transmission-blocking vaccine epitope publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/nsmb.3048 – volume: 182 start-page: 113 year: 2002 ident: 10.1016/j.bbcan.2021.188641_bb0385 article-title: Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions publication-title: Cancer Lett. doi: 10.1016/S0304-3835(02)00086-1 – volume: 122 start-page: 376 year: 2002 ident: 10.1016/j.bbcan.2021.188641_bb0105 article-title: Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer publication-title: Gastroenterology doi: 10.1053/gast.2002.31095 – volume: 63 start-page: 740 year: 2015 ident: 10.1016/j.bbcan.2021.188641_bb0490 article-title: Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients publication-title: J. Investig. Med. doi: 10.1097/JIM.0000000000000199 – volume: 13 start-page: 729 year: 1999 ident: 10.1016/j.bbcan.2021.188641_bb0365 article-title: Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines publication-title: Leukemia doi: 10.1038/sj.leu.2401388 – volume: 9 start-page: 1503 year: 2003 ident: 10.1016/j.bbcan.2021.188641_bb0455 article-title: Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma publication-title: Clin. Cancer Res. – volume: 1765 start-page: 148 year: 2006 ident: 10.1016/j.bbcan.2021.188641_bb0125 article-title: Methionine aminopeptidase 2 and cancer publication-title: Biochim. Biophys. Acta – volume: 23 start-page: 271 year: 2003 ident: 10.1016/j.bbcan.2021.188641_bb0030 article-title: CD13/aminopeptidase N in collagen vascular diseases publication-title: Rheumatol. Int. doi: 10.1007/s00296-003-0292-5 – volume: 46 start-page: 793 year: 2014 ident: 10.1016/j.bbcan.2021.188641_bb0025 article-title: Positioning of aminopeptidase inhibitors in next generation cancer therapy publication-title: Amino Acids doi: 10.1007/s00726-013-1648-0 – volume: 25 start-page: 1223 year: 2004 ident: 10.1016/j.bbcan.2021.188641_bb0390 article-title: The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer publication-title: Int. J. Oncol. – volume: 8 start-page: 66641 year: 2017 ident: 10.1016/j.bbcan.2021.188641_bb0555 article-title: Melflufen - a peptidase-potentiated alkylating agent in clinical trials publication-title: Oncotarget doi: 10.18632/oncotarget.18420 – volume: 109 start-page: 1637 year: 2012 ident: 10.1016/j.bbcan.2021.188641_bb0400 article-title: Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1120790109 – volume: 19 start-page: 39 year: 2008 ident: 10.1016/j.bbcan.2021.188641_bb0590 article-title: Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature publication-title: Bioconjug. Chem. doi: 10.1021/bc070031k – volume: 79 start-page: 1281 year: 2010 ident: 10.1016/j.bbcan.2021.188641_bb0515 article-title: The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2009.12.022 – volume: 48 start-page: 174 year: 1994 ident: 10.1016/j.bbcan.2021.188641_bb0295 article-title: Diagnostic significance of urinary enzymes for diabetes mellitus and hypertension publication-title: Enzyme Protein doi: 10.1159/000474984 – volume: 2 start-page: 67 year: 2001 ident: 10.1016/j.bbcan.2021.188641_bb0535 article-title: Bestatin as an experimental tool in mammals publication-title: Curr. Drug Metab. doi: 10.2174/1389200013338748 – volume: 357 start-page: 420 year: 1992 ident: 10.1016/j.bbcan.2021.188641_bb0320 article-title: Human aminopeptidase N is a receptor for human coronavirus 229E publication-title: Nature doi: 10.1038/357420a0 – volume: 95 start-page: 453 year: 2000 ident: 10.1016/j.bbcan.2021.188641_bb0270 article-title: CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34+ cells publication-title: Blood doi: 10.1182/blood.V95.2.453 – volume: 8 start-page: 762 year: 2009 ident: 10.1016/j.bbcan.2021.188641_bb0065 article-title: Aminopeptidase inhibition as a targeted treatment strategy in myeloma publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-08-0735 – volume: 19 start-page: 799 year: 2018 ident: 10.1016/j.bbcan.2021.188641_bb0595 article-title: NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial, the lancet publication-title: Oncology – volume: 63 start-page: 8500 year: 2003 ident: 10.1016/j.bbcan.2021.188641_bb0505 article-title: Biological significance of aminopeptidase N/CD13 in thyroid carcinomas publication-title: Cancer Res. – volume: 477 start-page: 1 year: 2000 ident: 10.1016/j.bbcan.2021.188641_bb0265 article-title: Review: the role of membrane peptidases in immune functions publication-title: Adv. Exp. Med. Biol. – volume: 79 start-page: 3344 year: 1992 ident: 10.1016/j.bbcan.2021.188641_bb0170 article-title: Deletion of the zinc-binding motif of Cd13/Aminopeptidase-N molecules results in loss of epitopes that mediate binding of inhibitory antibodies publication-title: Blood doi: 10.1182/blood.V79.12.3344.bloodjournal79123344 – volume: 43 start-page: 143 year: 1990 ident: 10.1016/j.bbcan.2021.188641_bb0530 article-title: Probestin, a new inhibitor of aminopeptidase-M, produced by streptomyces-azureus Mh663-2f6.1. Taxonomy, production, isolation, physicochemical properties and biological-activities publication-title: J. Antibiot. doi: 10.7164/antibiotics.43.143 – volume: 109 start-page: 17966 year: 2012 ident: 10.1016/j.bbcan.2021.188641_bb0180 article-title: Structural basis for multifunctional roles of mammalian aminopeptidase N publication-title: Proc. Natl. Acad. Sci. U. S. A doi: 10.1073/pnas.1210123109 – volume: 40 start-page: 1725 year: 1990 ident: 10.1016/j.bbcan.2021.188641_bb0250 article-title: Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M publication-title: Biochem. Pharmacol. doi: 10.1016/0006-2952(90)90348-O – volume: 68 start-page: 1105 year: 2008 ident: 10.1016/j.bbcan.2021.188641_bb0585 article-title: Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer publication-title: Prostate doi: 10.1002/pros.20775 – volume: 196 start-page: 385 year: 1991 ident: 10.1016/j.bbcan.2021.188641_bb0190 article-title: Functional residues at the active-site of aminopeptidase-N publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.1991.tb15828.x – volume: 67 start-page: 6576 year: 1993 ident: 10.1016/j.bbcan.2021.188641_bb0315 article-title: CD13 (human aminopeptidase N) mediates human cytomegalovirus infection publication-title: J. Virol. doi: 10.1128/jvi.67.11.6576-6585.1993 – volume: I start-page: 1020 issue: 94 year: 2002 ident: 10.1016/j.bbcan.2021.188641_bb0360 article-title: Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells publication-title: J. Natl. Cancer doi: 10.1093/jnci/94.13.1020 – volume: 21 start-page: 2135 year: 2013 ident: 10.1016/j.bbcan.2021.188641_bb0510 article-title: Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2012.12.038 – volume: 11 start-page: 8674 year: 2005 ident: 10.1016/j.bbcan.2021.188641_bb0110 article-title: Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer publication-title: clinical cancer research doi: 10.1158/1078-0432.CCR-05-1005 – volume: 8 start-page: 317 year: 2014 ident: 10.1016/j.bbcan.2021.188641_bb0040 article-title: Aminopeptidase activities as prospective urinary biomarkers for bladder cancer publication-title: Proteom. Clin. Appl. doi: 10.1002/prca.201300118 – volume: 28 start-page: 2604 year: 2010 ident: 10.1016/j.bbcan.2021.188641_bb0425 article-title: Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, previously treated patients with malignant pleural mesothelioma publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2009.27.3649 – volume: I year: 2018 ident: 10.1016/j.bbcan.2021.188641_bb0080 article-title: Molecular imaging of aminopeptidase N in cancer and angiogenesis publication-title: Contrast Media Mol. – volume: 14 start-page: 361 year: 2008 ident: 10.1016/j.bbcan.2021.188641_bb0210 article-title: The moonlighting enzyme CD13: old and new functions to target publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2008.06.003 – volume: 64 start-page: 1274 year: 1989 ident: 10.1016/j.bbcan.2021.188641_bb0045 article-title: Serum dipeptidyl peptidase activities as a possible marker of oral-cancer publication-title: Cancer doi: 10.1002/1097-0142(19890915)64:6<1274::AID-CNCR2820640618>3.0.CO;2-2 – volume: 291 start-page: 2364 year: 2001 ident: 10.1016/j.bbcan.2021.188641_bb0630 article-title: Intracellular functions of N-linked glycans publication-title: Science doi: 10.1126/science.291.5512.2364 – volume: 260 start-page: 3154 year: 1985 ident: 10.1016/j.bbcan.2021.188641_bb0545 article-title: The slow, tight-binding of bestatin and amastatin to aminopeptidases publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)38851-8 – volume: 105 start-page: 761 year: 1996 ident: 10.1016/j.bbcan.2021.188641_bb0290 article-title: Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms publication-title: Am. J. Clin. Pathol. doi: 10.1093/ajcp/105.6.761 – volume: 11 start-page: 223 year: 2015 ident: 10.1016/j.bbcan.2021.188641_bb0430 article-title: Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer publication-title: J. Cancer Res. Ther. doi: 10.4103/0973-1482.138007 – volume: 100 start-page: 74 year: 2013 ident: 10.1016/j.bbcan.2021.188641_bb0335 article-title: CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in mice publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvt155 – volume: 51 start-page: 1701610 year: 2018 ident: 10.1016/j.bbcan.2021.188641_bb0485 article-title: Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma publication-title: Eur. Respir. J. doi: 10.1183/13993003.01610-2017 – volume: 101 start-page: 219 year: 2009 ident: 10.1016/j.bbcan.2021.188641_bb0520 article-title: Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6605162 – volume: 54 start-page: 137 year: 1993 ident: 10.1016/j.bbcan.2021.188641_bb0405 article-title: Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation publication-title: Int. J. Cancer doi: 10.1002/ijc.2910540122 – volume: 12 start-page: 3971 year: 2006 ident: 10.1016/j.bbcan.2021.188641_bb0440 article-title: Clinical significance of aminopeptidase N in non-small cell lung cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-06-0338 – volume: 9 start-page: 22034 year: 2016 ident: 10.1016/j.bbcan.2021.188641_bb0460 article-title: Relation between the expression of aminopeptidase N(APN)/CD13 and the clinical significance in osteosarcomas publication-title: Int. J. Clin. Exp. Med. – volume: 97 start-page: 652 year: 2001 ident: 10.1016/j.bbcan.2021.188641_bb0420 article-title: CD13/APN is activated by angiogenic signals and is essential for capillary tube formation publication-title: Blood doi: 10.1182/blood.V97.3.652 – volume: 58 start-page: 1069 year: 2005 ident: 10.1016/j.bbcan.2021.188641_bb0470 article-title: Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma publication-title: J. Clin. Pathol. doi: 10.1136/jcp.2005.026328 – volume: 98 start-page: 331 year: 2013 ident: 10.1016/j.bbcan.2021.188641_bb0475 article-title: Expression of myeloid antigens on lymphoblast surface in childhood acute lymphoblastic leukemia at diagnosis and its effect on early response to treatment: a preliminary report publication-title: Int. J. Hematol. doi: 10.1007/s12185-013-1397-6 – volume: 216 start-page: 35 year: 2004 ident: 10.1016/j.bbcan.2021.188641_bb0095 article-title: Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice publication-title: Cancer Lett. doi: 10.1016/j.canlet.2004.06.050 – volume: 7 start-page: 1424 year: 2017 ident: 10.1016/j.bbcan.2021.188641_bb0135 article-title: The rational design of therapeutic peptides for aminopeptidase N using a substrate-based approach publication-title: Sci. Rep. doi: 10.1038/s41598-017-01542-5 – volume: 208 start-page: 664 year: 1995 ident: 10.1016/j.bbcan.2021.188641_bb0235 article-title: Substance P and bradykinin are natural inhibitors of CD13/Aminopeptidase N publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1995.1390 – volume: 303 start-page: F1584 year: 2012 ident: 10.1016/j.bbcan.2021.188641_bb0500 article-title: The impact of peptidase activity on clear cell renal cell carcinoma survival publication-title: Am. J. Physiol. – volume: 94 start-page: 185 year: 2011 ident: 10.1016/j.bbcan.2021.188641_bb0480 article-title: Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese pediatric leukemia/lymphoma study group publication-title: Int. J. Hematol. doi: 10.1007/s12185-011-0900-1 – volume: 87 start-page: 963 year: 2015 ident: 10.1016/j.bbcan.2021.188641_bb0620 article-title: Glycosylation patterns of kidney proteins differ in rat diabetic nephropathy publication-title: Kidney Int. doi: 10.1038/ki.2014.387 – volume: 285 start-page: 3310 year: 2010 ident: 10.1016/j.bbcan.2021.188641_bb0130 article-title: Aminopeptidase fingerprints, an integrated approach for identification of good substrates and optimal inhibitors publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.060418 – volume: 287 start-page: 36804 year: 2012 ident: 10.1016/j.bbcan.2021.188641_bb0165 article-title: The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.398842 – volume: 339 start-page: 186 year: 1963 ident: 10.1016/j.bbcan.2021.188641_bb0140 article-title: Isolation of an aminopeptidase from kidney particles publication-title: Biochem. Z. – volume: 77 start-page: 1008 year: 2005 ident: 10.1016/j.bbcan.2021.188641_bb0280 article-title: Aminopeptidase N (CD13) functionally interacts with FcgammaRs in human monocytes publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.1204714 – volume: 16 start-page: 1783 year: 2006 ident: 10.1016/j.bbcan.2021.188641_bb0495 article-title: Expression of aminopeptidase N/CD13 in human ovarian cancers publication-title: Int. J. Gynecol. Cancer doi: 10.1111/j.1525-1438.2006.00657.x – volume: 266 start-page: 4593 year: 1991 ident: 10.1016/j.bbcan.2021.188641_bb0155 – volume: 599 start-page: 448 year: 1980 ident: 10.1016/j.bbcan.2021.188641_bb0145 article-title: Rabbit intestinal aminopeptidase N. Purification and molecular properties publication-title: Biochim Biophys Acta doi: 10.1016/0005-2736(80)90190-X – volume: 259 start-page: 469 year: 1958 ident: 10.1016/j.bbcan.2021.188641_bb0050 article-title: Leucine aminopeptidase activity; observations in patients with cancer of the pancreas and other diseases publication-title: N. Engl. J. Med. doi: 10.1056/NEJM195809042591003 – volume: 94 start-page: 1627 year: 2006 ident: 10.1016/j.bbcan.2021.188641_bb0395 article-title: CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6603157 – ident: 10.1016/j.bbcan.2021.188641_bb0570 doi: 10.3390/cancers13071527 – volume: 354 start-page: 1 year: 1994 ident: 10.1016/j.bbcan.2021.188641_bb0185 article-title: Families of zinc metalloproteases publication-title: FEBS Lett. doi: 10.1016/0014-5793(94)01079-X – volume: 6 start-page: 243 year: 1992 ident: 10.1016/j.bbcan.2021.188641_bb0285 article-title: The significance of aminopeptidases and haematopoietic cell differentiation publication-title: Blood Rev. doi: 10.1016/0268-960X(92)90020-Q – volume: 24 start-page: 2179 year: 1985 ident: 10.1016/j.bbcan.2021.188641_bb0195 article-title: Identification of aminopeptidase-M as an enkephalin-inactivating enzyme in rat cerebral membranes publication-title: Biochemistry doi: 10.1021/bi00330a011 – volume: 7 start-page: e395 year: 2020 ident: 10.1016/j.bbcan.2021.188641_bb0575 article-title: Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study publication-title: Lancet Haematol. doi: 10.1016/S2352-3026(20)30044-2 – year: 2007 ident: 10.1016/j.bbcan.2021.188641_bb0325 article-title: Early events in human cytomegalovirus infection – volume: 108 start-page: 420 year: 2013 ident: 10.1016/j.bbcan.2021.188641_bb0465 article-title: Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer publication-title: Br. J. Cancer doi: 10.1038/bjc.2012.549 – volume: 26 start-page: 195 year: 2008 ident: 10.1016/j.bbcan.2021.188641_bb0560 article-title: The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro publication-title: Investig. New Drugs doi: 10.1007/s10637-007-9092-1 – volume: 8 start-page: 3747 year: 2002 ident: 10.1016/j.bbcan.2021.188641_bb0035 article-title: Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid publication-title: clinical cancer research – volume: 19 start-page: 6 year: 1996 ident: 10.1016/j.bbcan.2021.188641_bb0075 article-title: Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.19.6 – volume: 61 start-page: 6468 year: 2018 ident: 10.1016/j.bbcan.2021.188641_bb0340 article-title: Design of Aminopeptidase N Inhibitors as anti-cancer agents publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.7b00782 – volume: 59 start-page: 47 year: 2011 ident: 10.1016/j.bbcan.2021.188641_bb0605 article-title: Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues publication-title: J. Histochem. Cytochem. doi: 10.1369/jhc.2010.956644 – volume: 9 start-page: 6307 year: 2003 ident: 10.1016/j.bbcan.2021.188641_bb0020 article-title: Of peptides and peptidases: the role of cell surface peptidases in cancer publication-title: Clin. Cancer Res. – volume: 9 start-page: 6726 year: 2020 ident: 10.1016/j.bbcan.2021.188641_bb0580 article-title: Melflufen, a peptide-conjugated alkylator, is an efficient anti-neo-plastic drug in breast cancer cell lines publication-title: Cancer Med. doi: 10.1002/cam4.3300 – volume: 281 start-page: 23503 year: 2006 ident: 10.1016/j.bbcan.2021.188641_bb0115 article-title: Enzymatic properties of human aminopeptidase a: regulationofitsenzymaticactivitybycalciumandangiostensin IV publication-title: J. Biol. Chem. doi: 10.1074/jbc.M603191200 – volume: 75 start-page: 462 year: 1990 ident: 10.1016/j.bbcan.2021.188641_bb0200 article-title: Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells publication-title: Blood doi: 10.1182/blood.V75.2.462.462 – volume: 164 start-page: 129 issue: 2000 year: 1950 ident: 10.1016/j.bbcan.2021.188641_bb0275 article-title: Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells publication-title: J.Immunol. (Baltimore, Md.) – volume: 51 start-page: 127 year: 2009 ident: 10.1016/j.bbcan.2021.188641_bb0215 article-title: Analyses of cell surface molecules on hepatic stem/progenitor cells in mouse fetal liver publication-title: J. Hepatol. doi: 10.1016/j.jhep.2009.02.033 – volume: 57 start-page: 591 year: 2009 ident: 10.1016/j.bbcan.2021.188641_bb0435 article-title: Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer publication-title: Gen. Thorac. Cardiovasc. Surg. doi: 10.1007/s11748-009-0445-x – volume: 29 start-page: 561 year: 2012 ident: 10.1016/j.bbcan.2021.188641_bb0450 article-title: Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients publication-title: Med.Oncol. doi: 10.1007/s12032-011-9984-y – volume: 7 start-page: 32 year: 2011 ident: 10.1016/j.bbcan.2021.188641_bb0525 article-title: Xu, LYP3, a new bestatin derivative for aminopeptidase N inhibition publication-title: Med. Chem. doi: 10.2174/157340611794072706 – volume: 5 start-page: 151 year: 2004 ident: 10.1016/j.bbcan.2021.188641_bb0090 article-title: Aminopeptidase a is a functional target in angiogenic blood vessels publication-title: Cancer Cell doi: 10.1016/S1535-6108(04)00025-X – volume: 35 start-page: 2121 year: 2016 ident: 10.1016/j.bbcan.2021.188641_bb0380 article-title: Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells publication-title: Oncol. Rep. doi: 10.3892/or.2016.4611 – volume: 45 start-page: 1797 year: 1999 ident: 10.1016/j.bbcan.2021.188641_bb0010 article-title: Aminopeptidase activities in breast cancer tissue publication-title: Clin. Chem. doi: 10.1093/clinchem/45.10.1797 – volume: 263 start-page: 1277 year: 1960 ident: 10.1016/j.bbcan.2021.188641_bb0060 article-title: Clinical value of serum leucine aminopeptidase determinations publication-title: N. Engl. J. Med. doi: 10.1056/NEJM196012222632503 – volume: 7 start-page: 290 year: 1993 ident: 10.1016/j.bbcan.2021.188641_bb0005 article-title: Aminopeptidases - structure and function publication-title: FASEB J. doi: 10.1096/fasebj.7.2.8440407 – volume: 266 start-page: 11999 year: 1991 ident: 10.1016/j.bbcan.2021.188641_bb0230 article-title: Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)99056-3 – volume: 13 start-page: 293 year: 2008 ident: 10.1016/j.bbcan.2021.188641_bb0260 article-title: Aminopeptidase N in arterial hypertension publication-title: Heart Fail. Rev. doi: 10.1007/s10741-007-9061-y – volume: 7 start-page: 77854 year: 2016 ident: 10.1016/j.bbcan.2021.188641_bb0310 article-title: Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer publication-title: Oncotarget doi: 10.18632/oncotarget.12835 – volume: 33 start-page: 1372 year: 2015 ident: 10.1016/j.bbcan.2021.188641_bb0375 article-title: Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated publication-title: Oncol. Rep. doi: 10.3892/or.2014.3693 – volume: 26 start-page: 88 year: 2006 ident: 10.1016/j.bbcan.2021.188641_bb0415 article-title: Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects publication-title: Med. Res. Rev. doi: 10.1002/med.20044 – volume: 1862 start-page: 2069 year: 2018 ident: 10.1016/j.bbcan.2021.188641_bb0615 article-title: A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer publication-title: Biochim. Biophys. Acta Gen. Subj. doi: 10.1016/j.bbagen.2018.05.013 – volume: 68 start-page: 6669 year: 2008 ident: 10.1016/j.bbcan.2021.188641_bb0540 article-title: CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-6627 – volume: 104 start-page: 4588 year: 2007 ident: 10.1016/j.bbcan.2021.188641_bb0410 article-title: Impaired angiogenesis in aminopeptidase N-null mice publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0611653104 – volume: 69 start-page: 370 year: 1999 ident: 10.1016/j.bbcan.2021.188641_bb0255 article-title: PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III publication-title: Neuroendocrinology doi: 10.1159/000054439 – volume: 54 start-page: 36 year: 2007 ident: 10.1016/j.bbcan.2021.188641_bb0550 article-title: Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma publication-title: Hepato-Gastroenterology – volume: 107 start-page: 37 year: 2012 ident: 10.1016/j.bbcan.2021.188641_bb0600 article-title: Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients publication-title: Br. J. Cancer doi: 10.1038/bjc.2012.233 – volume: 62 start-page: 867 year: 2002 ident: 10.1016/j.bbcan.2021.188641_bb0225 article-title: Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells publication-title: Cancer Res. – start-page: 397 year: 2013 ident: 10.1016/j.bbcan.2021.188641_bb0240 article-title: Chapter 79 - aminopeptidase N – volume: 38 start-page: 698 year: 1960 ident: 10.1016/j.bbcan.2021.188641_bb0055 article-title: Serum leucine aminopeptidase in pancreatic and hepatobiliary diseases publication-title: Gastroenterology doi: 10.1016/S0016-5085(60)80084-4 – volume: 2021 year: 2021 ident: 10.1016/j.bbcan.2021.188641_bb0565 – volume: 15 start-page: 540 year: 2015 ident: 10.1016/j.bbcan.2021.188641_bb0635 article-title: Glycosylation in cancer: mechanisms and clinical implications publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3982 – volume: 23 start-page: 339 year: 1991 ident: 10.1016/j.bbcan.2021.188641_bb0015 article-title: Types and localization of aminopeptidases in different human blood-cells publication-title: Int. J. Biochem. doi: 10.1016/0020-711X(91)90116-5 – volume: 37 start-page: 686 year: 1998 ident: 10.1016/j.bbcan.2021.188641_bb0175 article-title: Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action publication-title: Biochemistry doi: 10.1021/bi971705p – volume: 102 start-page: 501 year: 2011 ident: 10.1016/j.bbcan.2021.188641_bb0305 article-title: Aminopeptidase N (CD13) as a target for cancer chemotherapy publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2010.01826.x – volume: 62 start-page: 91 year: 1982 ident: 10.1016/j.bbcan.2021.188641_bb0625 article-title: Topology of microvillar membrance hydrolases of kidney and intestine publication-title: Physiol. Rev. doi: 10.1152/physrev.1982.62.1.91 |
| SSID | ssj0015336 |
| Score | 2.5282245 |
| SecondaryResourceType | review_article |
| Snippet | Aminopeptidase N (APN/CD13) is a multifunctional glycoprotein that acts as a peptidase, receptor, and signalling molecule in a tissue-dependent manner. The... |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 188641 |
| SubjectTerms | Aminopeptidase Aminopeptidase N APN Cancer CD13 Protease |
| Title | Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique? |
| URI | https://dx.doi.org/10.1016/j.bbcan.2021.188641 https://www.proquest.com/docview/2586453396 |
| Volume | 1876 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED9Kxz5expZt9BsV9tDB3Fiy5MhPJWQraUdDYQvkTUiyBCmtE9YE2pf-7T1JdmGD9WGPli1j3x334fv5dwCffUFZLm2VVdK7jEsnM2mNyJzJhfEalR5BNBeTcjzl5zMx24BR9y9MgFW2vj_59Oit25V-K83-cj7v_wxNPU6rGaMxjwm025wPgpUfPzzBPEI6k_qVOQ8dz1nHPBQxXsbg82ORyOgxlbLk9F_R6S8_HYPP6Tt422aNZJge7D1suKYHL9McyfsevB51Y9t68Oqi7ZZ_gOnZLVmtsbb_nbm7CHh1NdE382axDFiWGgMYmZCj4eWkP_pGiy8kkckGIo7re6KbmoSolz4W4sI6cr2efITp6fdfo3HWjlHILL77KhvUzqIOdCFtTrXVNddYguraV9zk1OqioloKKyz3WnsmmHVUaibpwHvUGC8-wWazaNwWkCKQ0aBQfVUbrHRK7UrhQ4ooGDpOU2wD68SnbMsxHkZdXKsOTHalosxVkLlKMt-Gr0-bloli4_nLy04v6g9LURgEnt942GlRoU5CY0Q3brG-VUzgeTSUqtz535vvwptwlIAue7CJ-nL7mK6szEG0xwN4MTz7MZ48Ahqg5-8 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFH8aQzAuExQQYx94EgeQyBo7duacpqlj6thaIbFKvVm2Y0tFI61YK7ELfzvPdjJpSNthVzuO4t9z3kfeL-8BfPQFZbm0VVZJ7zIuncykNSJzJhfGaxR6JNGMxuVwwr9NxXQNBt2_MIFW2er-pNOjtm5H-i2a_cVs1v8RknqcVlNGox9TPoGnHF_f0Mbg4O8tzyP4MylhmfOQ8px2pYciycsY3ABGiYweUClLTu8zT_8p6mh9Tl_CZus2kuP0ZK9gzTU9eJYaSd70YGPQ9W3rwfNRmy5_DZOza7JcYXD_O3N_IuPV1UT_mjXzRSCz1GjByJh8Ov4-7g9OaPGZpGqyoRLH1Q3RTU2C2UtfC3FgFYu9Hr2ByenXy8Ewa_soZBb3vswOa2dRCLqQNqfa6pprjEF17Stucmp1UVEthRWWe609E8w6KjWT9NB7FBkv3sJ6M2_cOyBFqEaDoPqqNhjqlNqVwgcfUTCE3hRbwDr4lG2LjIdeF1eqY5P9VBFzFTBXCfMt-HK7aJFqbDx8ednJRd05KgqtwMML9zspKpRJyIzoxs1X14oJnMeDUpXvH3vzD7AxvBxdqIuz8fk2vAgzifWyA-soO7eLvsvS7MWz-Q94SOl9 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+tumour-expressed+aminopeptidase+N+%28APN%2FCD13%29+structurally+and+functionally+unique%3F&rft.jtitle=Biochimica+et+biophysica+acta.+Reviews+on+cancer&rft.au=Barnieh%2C+Francis+M&rft.au=Loadman%2C+Paul+M&rft.au=Falconer%2C+Robert+A&rft.date=2021-12-01&rft.issn=1879-2561&rft.eissn=1879-2561&rft.volume=1876&rft.issue=2&rft.spage=188641&rft_id=info:doi/10.1016%2Fj.bbcan.2021.188641&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-419X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-419X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-419X&client=summon |